chr15-48488112-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000138.5(FBN1):c.3337+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000138.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Marfan syndrome Pathogenic:3
PM2, PS7, PP4 -
The intronic c.3337+1G>A variant was reported in one Chinese patient with aortic disease and was tested positive for a pathogenic mutation (PMID: 27611364). The variant is absent from large population studies (ExAC no frequency). ClinVar has an entry for this variant (Variation ID: 42331). There are known 3 other variants at this position: c.3337+1G>T, c.3337+1G>C, c.3337+1delG; two reported on the ClinVar (Variation ID: 527150, 574182) and one was studied in relation with MFS (PMID: 16220557). The c.3337+1G position is canonical splice site donor, all above reports on alteration of this nucleotide position show disruption of normal RNA splicing. Based on this evidences the c.3337+1G>A variant is classified as Pathogenic. -
- -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 42331). Disruption of this splice site has been observed in individuals with clinical features of FBN1-related conditions (PMID: 16220557, 24793577, 33174221). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 27 of the FBN1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at